2001-February Archives by Subject

• Messages sorted by: [ thread ] [ author ] [ date ]
• More info on this list...

Starting: Thu Feb 1 09:51:03 2001
Ending: Wed Feb 28 07:12:08 2001
Messages: 102

• [Pharm-policy] (no subject)   pkorthui@ucla.edu
• [Pharm-policy] 3/5/01: Protest in Philly and DC   Julie Davids
• [Pharm-policy] [Fwd: US Congress Letter to Bush to HIV/AIDS Pharmaceuticals]   Mike Palmedo
• [Pharm-policy] Aaron Zitner, Genes and Patent disputes   James Love
• [Pharm-policy] Activists Take Over GlaxoSmithKline Investor Relations Office   James Love
• [Pharm-policy] AFL-CIO resolution on FTAA; good provisions on IP (fwd)   Robert Weissman
• [Pharm-policy] Australian PBAC: Wooldridge accused as drug revolt grows   James Love
• [Pharm-policy] Australian Pharmaceutical Benefits Scheme: more trouble   James Love
• [Pharm-policy] Bangladesh Industries Minister asks for LDC extention on TRIPS compliance   love@cptech.org
• [Pharm-policy] BBC: Thais battle firms over AIDS drugs   love@cptech.org
• [Pharm-policy] BioChem evergreening of 3TC patent   love@cptech.org
• [Pharm-policy] BMS, Pfizer ask CIPLA for time to respond to voluntary license request   James Love
• [Pharm-policy] Boehringer-Ingelheim firm on SA patent lawsuit   love@cptech.org
• [Pharm-policy] Brazil asks WTO to examine US local working requirements in federally funded inventions   love@cptech.org
• [Pharm-policy] Brazil Compulsory License Law   James Love
• [Pharm-policy] Brazil/WTO case: USTR Response to Gregg Gonsalves   James Love
• [Pharm-policy] Britain dangles tax breaks for drugs groups helping developing world   James Love
• [Pharm-policy] Brundtland on CIPLA to staff   James Love
• [Pharm-policy] CBC Transcript "The Situation of People Infected with HIV in Sub-Saharan Africa"   James Love
• [Pharm-policy] Chris Adams in WSJ on commericalization of chris.adams@wsj.comfederally funded R&D   love@cptech.org
• [Pharm-policy] CIPLA offers $350 yr 3 drug cocktail to MSF   James Love
• [Pharm-policy] Cipla on its offer   Mike Palmedo
• [Pharm-policy] CIPLA to offer Indinavir, Efavirenz, drops Indian prices   James Love
• [Pharm-policy] CPT comment on US/Brazil dispute   love@cptech.org
• [Pharm-policy] CPT reaction to MSF CIPLA joint statement   James Love
• [Pharm-policy] CPT response to Linda Horton   James Love
• [Pharm-policy] Crisis in the Australian PBS (cont)   James Love
• [Pharm-policy] David Henry, an unlikely villain?   James Love
• [Pharm-policy] Declan Walsh on Kenyan AIDS orphanage civil disobedience   love@cptech.org
• [Pharm-policy] Dorothy Guellec: The real scoop on Patient Assistance Programs   James Love
• [Pharm-policy] Drug Industry Jolted by Cipla AIDS-Drug Offer   James Love
• [Pharm-policy] FDA Orange Book patents web site   James Love
• [Pharm-policy] formatting fixed: Brundtland on CIPLA to staff   James Love
• [Pharm-policy] FYI-GMHC to USTR on Brazil   Gonsalves, Gregg
• [Pharm-policy] Glaxo clashes with Tshabalala-Msimang on AIDS drug prices   love@cptech.org
• [Pharm-policy] Glaxo response on CIPLA/Ghana dispute   James Love
• [Pharm-policy] Glaxo's claims of patent protection on antiretrovirals in Ghana   Toby Kasper
• [Pharm-policy] Hatch/Waxman and 30 month period after patent infringment issue is raised   James Love
• [Pharm-policy] Heimboldsheart.com   James Love
• [Pharm-policy] Hindu on CIPLA offer   James Love
• [Pharm-policy] India drug export sales surge   love@cptech.org
• [Pharm-policy] India to block import of cheap drugs from China and Taiwan   love@cptech.org
• [Pharm-policy] Joint MSF/CIPLA statement   James Love
• [Pharm-policy] Ken Harvey's Feb 1 comments on Australian PBAC problems   James Love
• [Pharm-policy] Kenya debate over CIPLA offer   love@cptech.org
• [Pharm-policy] Kenya: Anger over drug prices   love@cptech.org
• [Pharm-policy] LA Times on Bush/USTR AIDS policy   love@cptech.org
• [Pharm-policy] Lancet editorial on South Africa Patent dispute   James Love
• [Pharm-policy] Linda Horton on TACD and generic quality   James Love
• [Pharm-policy] Linkage of Patents and drug registration   James Love
• [Pharm-policy] Malaysia: Allow ASEAN to make anti-AIDS drugs   love@cptech.org
• [Pharm-policy] MNCs allege Cipla's African `aid' violates patent   love@cptech.org
• [Pharm-policy] More on Australian PBS   Mike Palmedo
• [Pharm-policy] Morton Mintz earlier US debate on compulsory licensing, from Kefauver's hearings   James Love
• [Pharm-policy] MSF Open Letter to Pascal Lamy re South Africa   James Love
• [Pharm-policy] NYT: Bush Keeps Clinton Policy on Poor Lands' Need for AIDS Drugs   Paul Davis
• [Pharm-policy] Nytimes editorial: bush admin & Fighting AIDS in Africa   James Love
• [Pharm-policy] Oxfam attacks Glaxo over price of Aids drugs   love@cptech.org
• [Pharm-policy] Oxfam Drug campaign in the news   Mike Palmedo
• [Pharm-policy] Philly Inquirer: Piot says Patent Deal Doesn't Work for the South   Paul Davis
• [Pharm-policy] PhRMA on price cuts   James Love
• [Pharm-policy] R&D on cheaper HIV testing technologies   James Love
• [Pharm-policy] Rachel Zimmerman: WSJ on Pediatric patent extention   James Love
• [Pharm-policy] Ranbaxy to foray into anti-AIDS drugs market   love@cptech.org
• [Pharm-policy] Raw Materials prices for HIV drugs   James Love
• [Pharm-policy] RE: [Ip-health] Brazil Compulsory License Law   Toby Kasper
• [Pharm-policy] RE: [Ip-health] Dorothy Guellec: The real scoop on Patient Assistance Programs   James Love
• [Pharm-policy] RE: [Ip-health] HIV testing patents   Gonsalves, Gregg
• [Pharm-policy] RE: [Ip-health] HIV testing patents   Gonsalves, Gregg
• [Pharm-policy] RE: [Ip-health] HIV testing patents   Gonsalves, Gregg
• [Pharm-policy] Re: [Ip-health] HIV testing patents   Ezio Santos-Filho
• [Pharm-policy] RE: [Ip-health] HIV testing patents   richardl@bu.edu
• [Pharm-policy] Re: Guardian article today.   Alan Story
• [Pharm-policy] RE: R&D on cheaper HIV testing technologies   richardl@bu.edu
• [Pharm-policy] RE: R&D on cheaper HIV testing technologies   Gonsalves, Gregg
• [Pharm-policy] Re:CIPLA offers $350 yr 3 drug cocktail to MSF   Kate Krauss
• [Pharm-policy] Richard Laing on generic quality   James Love
• [Pharm-policy] Richard Stern on what needs to be done next   James Love
• [Pharm-policy] Simon Barber take on Bush announcement   James Love
• [Pharm-policy] TAC Statement on CIPLA -- Minister Erwin Issue Compulsory Licences Now!   James Love
• [Pharm-policy] TAC Statement on Democratic Alliance -- 15 February 2001   James Love
• [Pharm-policy] TAC statement on US/Brazil complaint   James Love
• [Pharm-policy] Teva's 1999 testimony on abuse of FDA 30 month rule   James Love
• [Pharm-policy] The Hindu on Ranbaxy entry in HIV market   love@cptech.org
• [Pharm-policy] Time Magazine Story   Mike Palmedo
• [Pharm-policy] Tshabalala-Msimang on CIPLA offer   love@cptech.org
• [Pharm-policy] Uganda: Glaxo's Nov 20 letter CIPLA reg Duovir   love@cptech.org
• [Pharm-policy] UNAIDS call for compulsory licensing and price cuts   love@cptech.org
• [Pharm-policy] UPI story on Brazil   Mike Palmedo
• [Pharm-policy] US lawmaker to seek compulsory license for Napster!   James Love
• [Pharm-policy] USTR statement on HIV/AIDS and trade policy   James Love
• [Pharm-policy] USTR to continue "flexiable" trade policy on access to medicines   James Love
• [Pharm-policy] Washington Post Editorial   MFJorge@aol.com
• [Pharm-policy] Washington Post editorial: Patent Wrongs   James Love
• [Pharm-policy] Washington Post: U.S., Brazil Clash Over AIDS Drugs   James Love
• [Pharm-policy] Washington Post: S. Africa Relents on Maternal HIV Care   Mike Palmedo
• [Pharm-policy] WHO statement of CIPLA offer   love@cptech.org
• [Pharm-policy] WHO Statement on CIPLA offer   James Love
• [Pharm-policy] WP- Kenyan Orphanage Takes Initiative on AIDS Drugs   Mike Palmedo
• [Pharm-policy] WSJ on Brazil WTO case   love@cptech.org
• [Pharm-policy] WSJ on CIPLA offer   love@cptech.org
• [Pharm-policy] WSJ on CIPLA's voluntary license request   love@cptech.org

Last message date: Wed Feb 28 07:12:08 2001
Archived on: Wed Feb 28 07:12:09 2001

• Messages sorted by: [ thread ] [ author ] [ date ]
• More info on this list...